0001209191-19-046917.txt : 20190820 0001209191-19-046917.hdr.sgml : 20190820 20190820203847 ACCESSION NUMBER: 0001209191-19-046917 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190819 FILED AS OF DATE: 20190820 DATE AS OF CHANGE: 20190820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zeidan Ryan CENTRAL INDEX KEY: 0001785724 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35890 FILM NUMBER: 191041122 MAIL ADDRESS: STREET 1: C/O MILLENDO THERAPEUTICS, INC. STREET 2: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Millendo Therapeutics, Inc. CENTRAL INDEX KEY: 0001544227 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 451472564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 BUSINESS PHONE: 734-845-9000 MAIL ADDRESS: STREET 1: 110 MILLER AVENUE, SUITE 100 CITY: ANN ARBOR STATE: MI ZIP: 48104 FORMER COMPANY: FORMER CONFORMED NAME: OvaScience, Inc. DATE OF NAME CHANGE: 20120308 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-19 0 0001544227 Millendo Therapeutics, Inc. MLND 0001785724 Zeidan Ryan C/O MILLENDO THERAPEUTICS, INC 110 MILLER AVENUE, SUITE 100 ANN ARBOR MI 48104 0 1 0 0 Chief Development Officer Employee Stock Option (right to buy) 7.27 2019-08-19 4 A 0 10000 0.00 A 2029-08-18 Common Stock 10000 10000 D Twenty-five percent (25%) of the shares subject to this option shall vest on August 19, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Tamara Joseph, Attorney-in-Fact 2019-08-20